	First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial. Nat Cancer Schmid P, Im SA, Nowecki Z, Wysocki PJ, Jassem J, Jung KH, Lord S, Armstrong J, Stewart R, Vukovi, Denduluri N, Park YH. PMID: 42259988 [PubMed - as supplied by publisher]
	Evaluating machine learning algorithms based on thermal imaging and milk-based parameters to identify subclinical mastitis in dairy cows. Vet Q Paudyal S, Neupane R, Shrestha B, Chiang HI, Aryal A. PMID: 42259761 [PubMed - in process]
	International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer. Eur J Surg Oncol Lucocq J, Karakatsanis A, Kirwan C, Boughey J, Tseng J, Sun SX, Gentilini OD, Barber M, Chagla L, Buccimazza I, Dick L, Massannat Y, Dixon JM, Kühn T, Benson J, Elder K, NAC-AX Collaborative Group. PMID: 42259722 [PubMed - as supplied by publisher]
	Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer. ESMO Open Salehi E, Chu X, Mayer EL, Singer S, Augdahl G, Stalteri M, Li T, Dibble KE, Sinclair N, Faggen M, Walsh J, Sammons S, Sendrick K, Hanna S, Mostaghimi A, Tayob N, LeBoeuf NR, Tolaney SM. PMID: 42258966 [PubMed - as supplied by publisher]
	Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies. J Clin Oncol Braunstein LZ, Mitchell MP, Khan AJ, Sikov WM, Mamounas EP, Julian TB, Wolmark N. PMID: 42258793 [PubMed - as supplied by publisher]
	The Development of Ultrasound Intervention in the Diagnosis and Treatment of Non-breast Superficial and Abdominal Diseases. J Vis Exp Du T, Leng WJSG, Wa Z. PMID: 42258485 [PubMed - in process]
	SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes. Clin Transl Oncol Oses G, Clavell C, González-Farré B, Sanfeliu E, Laplana M, Martínez A, Moreno S, Meca G, Gomis E, Carreras-Ballvé J, Mension E, Cebrecos I, Caparrós X, Tarrats-Rosell J, Cases C, Herreros A, Mollà M. PMID: 42258139 [PubMed - as supplied by publisher]
	Withaferin A in breast cancer therapy: multi-targeted modulation of redox homeostasis, autophagy, and apoptosis. J Asian Nat Prod Res Patel N, Gupta A, Mishra R, Pandey SN, Goyal K, Ali H, Maji C, Rekha A, Hussain MS, Singh SK, Gupta G. PMID: 42257714 [PubMed - as supplied by publisher]
	Dynamic breast magnetic resonance imaging features and pathological correlation of patients diagnosed with breast cancer under the age of 40. Acta Radiol Gundogdu V, Meltem E, Ulusan MB, Bozkurt H, Mahmutoglu AS. PMID: 42257534 [PubMed - as supplied by publisher]
	Ipsilateral Breast Tumor Detected 20 Years after Occult Breast Cancer: A Diagnostic Challenge in Distinguishing New Primary Cancer from Late Recurrence. Case Rep Oncol Masuda Y, Tanaka M, Koga Y, Eto K, Watanabe R, Yoshinaga Y, Satou T. PMID: 42257037 [PubMed]
	Non-pharmacological sleep management in breast cancer survivors: Evidence from a systematic review and meta-analysis of RCTs. Prev Med Rep Aemmi SZ, Mohammadi-Pirouz Z, Moradi M. PMID: 42256805 [PubMed]
	Financial incentives for women's cervical, breast and colorectal cancer screening adherence: systematic review and meta-analysis. Prev Med Rep Lumia C, Nespoli A, Ausili D, Fumagalli S, Dumont A. PMID: 42256798 [PubMed]
	The Effect of a Program Based on the Common-Sense Model on Illness Perception and Health-Promoting Behaviors in Women with Breast Cancer: A Randomized Clinical Trial Study. Iran J Nurs Midwifery Res Bahrami M, Musarezaie A, Alidousti F. PMID: 42256750 [PubMed]
	Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy. Toxicol Rep Heilat GB, Alwidyan T, Alrosan AZ, Rataan AO, Alrosan K, Ahmad RB, Al-Kammash KR. PMID: 42255660 [PubMed]
	Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study. Front Oncol Yoo J, Park HH, Kim SY, Ahn SJ, Ahn J, Oh J, Lim J. PMID: 42255246 [PubMed]
	Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer. Front Oncol Saadatkhah A, Nicholson L, Buchholz TA, Hong L. PMID: 42255244 [PubMed]
	Prognostic evaluation using nutrition-inflammation biomarkers from routine blood tests in metastatic breast cancer: a Boruta algorithm-optimized feature selection study. Front Oncol Nong WX, Huang SK, Zhang WH, Tan Y, Wu ZD, Liang WW, Wu RZ. PMID: 42255236 [PubMed]
	(18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors. Adv Radiat Oncol Kubeczko M, Sousa B, Oliveira F, Constantino C, Duarte C, Castanheira J, Matos L, Kocio, Jarz, Costa D, Cardoso F, Morales J, Greco C, Vasconcelos AL. PMID: 42254818 [PubMed]
	A study on the application of range shifter and bolus in spot-scanning proton arc (SPArc) therapy after modified radical mastectomy for left-sided breast cancer. Front Public Health Zhou L, He Y, Shen S, Wang X, Jia S, Feng H, Yang X, Zeng X. PMID: 42254623 [PubMed - in process]
	Factors Driving Low Rates of Post-Mastectomy Breast Reconstruction in Low- and Middle-Income Countries: A Systematic Review. J Plast Reconstr Surg Giwa G, Ahmed K, J Davis A, Dewan A, Seal S, Mundy L, Broderick K. PMID: 42254559 [PubMed]

Articles 1 - 20 / 218542

Page 1 of 10928



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy